BeCytes Biotechnologies

✨ You get the best of both worlds What does organoid culture on microfluidic chips offer? 👀 Take a look at this interesting review of the convergence of microphysiological systems and organoids: https://lnkd.in/dB5ANTUs We know the importance of organoid generation in in vitro hepatic models. 🔵 That's why our certificate of analysis includes a section describing whether a specific batch of human primary hepatic cells can generate liver organoids. Check it out! #microfluidics #organoids #drugscreening #organonachip #BeCytes

🚨 Publication alert 🚨 Natalia Sánchez Romero, R&D Director, had the pleasure of contributing to the last number of Farmabiotec, the applied biotechnology to healthcare journal. She reflects on the progress of 3D in vitro liver models for drug screening in preclinical phases. 👀 Check it out: https://lnkd.in/dZwJXDwi #Farmabiotec #3Dmodels #drugscreening #livermodels #BeCytesBiotechnologies

🧬 Today, I had the privilege of attending the 36th EORTC NCI AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona. This event focused on the latest global trends in optimizing in vitro preclinical models for drug development. #ENASymp24 A key highlight was the emphasis on the essential role that high-quality biological samples play in advancing these processes. The ability to deliver top-tier samples is crucial for enhancing the predictability and effectiveness of preclinical studies. 🧫🔬 These discussions reaffirm BeCytes Biotechnologies ‘s commitment to excellence and innovation in providing human tissues and cells for research. We remain dedicated to supporting the development of more efficient and precise preclinical models that propel the future of human health. 🚀🧪 #Research #PreclinicalModels #Innovation #MolecularTherapeutics #Biotechnology #DrugDevelopment #CytesBiotechnologies #Barcelona #TissueForResearch 🌍

Difficult access to primary hepatocytes used to be one of their main drawbacks. Until it was not. ✅ BeCytes grants access to human primary hepatocytes sourced from meticulously characterized donor tissues. Rigorous testing ensures they meet the highest viability, purity, and functional activity standards. What are the advantages of using primary hepatocytes? How do hepatocytes stand out from immortalized cell lines? 🤓 Read our last blog to discover it: https://lnkd.in/dKUxvb6v #primaryhepatocytes #cellculture #hepg2 #livercells #BeCytes

👀 Exciting event in sight! Estephan Arredondo, our Technical Director, will attend the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024). 🗓️ 23-25 October 📍 Barcelona, Spain It will be a great opportunity to discuss how BeCytes can provide cancer biospecimens to develop your research in vitro models. Let's chat! 🫱🏻🫲🏽 EORTC - European Organisation for Research and Treatment of Cancer | #ENASYMP24 #CancerResearch #Oncology #BeCytesBiotechnologies

🤔 Will these primary liver cells form organoids? Our certificate of analysis now includes organoid generation capability! 💥 Besides having a section for spheroid formation, the certificate of analysis includes a new section describing whether a specific batch of human primary hepatic cells can generate liver organoids. This information is available for primary hepatocytes and non-parenchymal cells. Check it out in our inventory! https://lnkd.in/dtS2GY2R #organoids #spheroids #primarylivercells #cellculture #BeCytes

Liver-on-a-chip to address drug genotoxicity? 🧬 It will soon be a must! 🔵Discover why in our latest blog: https://lnkd.in/dEEqxQEd #liveronachip #genotoxicity #drugscreening #cellculture #BeCytes

🔬 Proudly presenting the UNLOOC consortium partners, boasting an extensive network of 51 organisations from 10 countries! In the coming months we will introduce each partner and the related use cases - all making groundbreaking research in the area of organ-on-chips. 🔬The UNLOOC project is coordinated by microfluidic ChipShop GmbH from Germany. An innovation consulting company Spinverse from Finland provides the consortium with administrative services. 🔬 This project is supported by the Chips Joint Undertaking (Grant Agreement No. 101140192) and its members including the top-up funding of Belgium, Germany, Hungary, Ireland, Italy, the Netherlands, Portugal, Romania and Spain. This work has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI). 🤩 Stay tuned for our posts on this channel! #UNLOOCChipsJU #unlooc #OrganOnChip #consortium #FutureOfMedicine #EUresearch

🇯🇵 We've arrived in Osaka! 🤝 On the first day of this visit to Japan, #Biocat representants, alongside with Japan Mission 2024 participants, have participated in the EU-Japan Biotechnology & Pharma Conference. ✅ The Japan Mission has the support of the Department of Foreign Affairs, and we will be accompanied by the @Mònica Castellà Pujadó, Head of the Delegation of the Government of Catalonia in Japan. 🙌 We are proud to be part of this event organized by the @EU-Japan Centre for Industrial Cooperation and the Osaka Prefecture Government. The first day was marked by the recognition of the strategic power of the #BioRegionCatalonia. On the first day, we've made contacts with Japanese clusters and universities such as Kagoshima University and Kyushu University. It has been a great opportunity to connect and think about strategies for Osaka Expo 2025. 🗨 Núria Martí Ras, director of innovation at Biocat, was able to present the #BioRegionCatalonia, as well as its capabilities and #Biocat's lines of action to all congress participants. 💡 Carme Plasencia, CEO of AROMICS Biotech and Martí Dalmases Arnella, from Ahead Therapeutics, have been able to do their pitches and explore synergies. 💊 Catalan presentations also arose the interest of big Japanese pharma companies. ✔ During the second day, we've participated in the ICEX program with different sessions with representants from Japan's ecosystem. Japan Bioindustry Association, an association with 600 individuals and 505 corporates, has presented Japan's #biotech and #medtech ecosystem. At the Pharmaceuticals and Medical Device Agency session, they've analyzed the regulation of drug developing and discovering in Japan. ✔ The delegation also met with the Spanish ambassador in Japan, Fidel Sendagorta, and the commercial counselor of Japan, Gonzalo Ramos Puig, to talk about the challenges of the sector and what do our companies and entities need to strengthen the collaborations and the relationship with Japan. ✔ We've also visited Life Science Innovation Network Japan (LINK-J), the Japanese association in Tokyo that covers all the companies and stakeholders in the sector, where Núria Martí Ras, director of innovation at Biocat, explained the BioRegion's ecosystem. 🔴 Now BioJapan 2024 is waiting for us! Stay tuned for more updates as we continue to strengthen our international collaborations!

Busy days in Japan! 🇯🇵 Natalia Sánchez Romero, R&D Director, attended exciting events this week: 🫱🏼🫲🏽 The Global Life Science Session 2024, organized by Life Science Innovation Network Japan (LINK-J), where she presented the science behind our services. 🫱🏼🫲🏽 The pre-congress networking event organized by ICEX at the Spanish Embassy in Tokyo. 🫱🏼🫲🏽 A meeting with our distributor in Japan, KAC Co.,Ltd. It has been a great opportunity to reinforce our current partnerships and discuss future ones. 🚨 From today Natalia will attend BioJapan 2024 at PACIFICO Yokohama. Find her at the Biocat, BioRegion of Catalonia booth. We are willing to meet you! AseBio - Asociación Española de Bioempresas | BioJapan / JTB Communication Design | #BioJapan #partnering #primarylivercells #tissuesourcing #BeCytes